SHEN, G. et al. SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2012, 2012, vol. 59, no. 5, s. 486-493.